Interleukin 33 mediates type 2 immunity and inflammation in the central nervous system of mice infected with Angiostrongylus cantonensis

Journal of Infectious Diseases

Volumn 207, Issue 5, 2013, Pages 860-869

  Peng, Hui ^a   Sun, Rui ^a,b   Zhang, Qixian ^a,b   Zhao, Jia ^a,b   Wei, Jie ^a,b   Zeng, Xin ^a,b   Zheng, Huanqin ^a,b   Wu, Zhongdao ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiostrongylus cantonensis; CNS; IL 33; ST2L

Indexed keywords

ARGINASE 1; CYTOKINE; EOTAXIN 2; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; MESSENGER RNA; ST2L PROTEIN; UNCLASSIFIED DRUG;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL COUNT; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MENINGITIS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SPLEEN CELL; TH2 CELL;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MONOCYTES; RECEPTORS, INTERLEUKIN-1; SPLEEN; STRONGYLIDA INFECTIONS; TH2 CELLS;

EID: 84873622214     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis682     Document Type: Article

References (28)

1. Wang QP, Lai DH, Zhu XQ, Chen XG, Lun ZR. Human angiostrongyliasis. Lancet Infect Dis 2008; 8:621-30
2. Wang X, Huang H, Dong Q, et al. A clinical study of eosinophilic meningoencephalitis caused by angiostrongyliasis. Chin Med J (Engl) 2002; 115:1312-5
3. Sinawat S, Sanguansak T, Angkawinijwong T, et al. Ocular angiostrongyliasis: Clinical study of three cases. Eye (Lond) 2008; 22:1446-8
4. Wang QP, Wu ZD, Wei J, Owen RL, Lun ZR. Human Angiostrongylus cantonensis: An update. Eur J Clin Microbiol Infect Dis 2012; 31: 389-95
5. Anthony RM, Rutitzky LI, Urban JJ, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007; 7:975-87
6. Sasaki O, Sugaya H, Ishida K, Yoshimura K. Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse. Parasite Immunol 1993; 15:349-54
7. Yoshida T, Ikuta K, Sugaya H, et al. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 1996; 4:483-94
8. Sugaya H, Aoki M, Yoshida T, Takatsu K, Yoshimura K. Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor alpha chain-knockout mice infected with Angiostrongylus cantonensis. Parasitol Res 1997; 83:583-90
9. Sugaya H, Aoki M, Abe T, Ishida K, Yoshimura K. Cytokine responses in mice infected with Angiostrongylus cantonensis. Parasitol Res 1997; 83:10-5
10. Sugaya H, Abe T, Yoshimura K, Sasaki O. Antigen dependent release of interleukin 5 in vitro from spleen cells of mice infected with Angiostrongylus cantonensis. Int J Parasitol 1993; 23:865-9
11. Paul WE, Zhu J. How are T(H)2-Type immune responses initiated and amplified? Nat Rev Immunol 2010; 10:225-35
12. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 2005; 23: 479-90
13. Kurowska-Stolarska M, Stolarski B, Kewin P, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183:6469-77
14. Roldan WH, Espinoza YA, Huapaya PE, Huiza AF, Sevilla CR, Jimenez S. Frequency of human toxocariasis in a rural population from Cajamarca, Peru determined by DOT-ELISA test. Rev Inst Med Trop Sao Paulo 2009; 51:67-71
15. Koyasu S, Moro K. Type 2 innate immune responses and the natural helper cell. Immunology 2011; 132:475-81
16. Kaiko GE, Foster PS. New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma. Curr Opin Allergy Clin Immunol 2011; 11:39-45
17. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010; 59: 143-60
18. Jones LA, Roberts F, Nickdel MB, et al. IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol 2010; 40:426-36
19. Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008; 180:2443-9
20. Choi YS, Choi HJ, Min JK, et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 2009; 114:3117-26
21. Hu X, Li JH, Lan L, et al. In vitro study of the effects of Angiostrongylus cantonensis larvae extracts on apoptosis and dysfunction in the blood-brain barrier (BBB). PLoS One 2012; 7:e32161
22. Lee JD, Tsai LY, Chen CH, Wang JJ, Hsiao JK, Yen CM. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop 2006; 97:204-11
23. Bourgeois E, Van LP, Samson M, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFNgamma production. Eur J Immunol 2009; 39:1046-55
24. Hazlett LD, McClellan SA, Barrett RP, et al. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2010; 51:1524-32
25. Kurowska-Stolarska M, Kewin P, Murphy G, et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008; 181:4780-90
26. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121:1484-90
27. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010; 185:3472-80
28. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009; 179:772-81